Neuroblate
Payments companies reported to CMS as associated with Neuroblate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuroblate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuroblate
These are the largest totals companies reported as associated with Neuroblate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Fecci | Aurora, CO | Neurological Surgery | $76,522.69 |
| Joseph Neimat | Louisville, KY | Neurological Surgery | $39,412.39 |
| Albert Kim | Saint Louis, MO | Neurological Surgery | $21,570.92 |
| Orin Bloch | Sacramento, CA | Neurological Surgery | $17,630.69 |
| John Phillips | Nashville, TN | Radiation Oncology | $17,594.11 |
| Adrian Laxton | Winston Salem, NC | Neurological Surgery | $16,454.69 |
| Gene Barnett | Cleveland, OH | Neurological Surgery | $15,847.06 |
| Ian Lee | Detroit, MI | Neurological Surgery | $10,710.18 |
| John Kirkpatrick | Durham, NC | Radiation Oncology | $9,384.43 |
| Michael Chan | Winston Salem, NC | Radiation Oncology | $8,986.29 |
Prescribed Neuroblate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.